Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data

被引:3
|
作者
Van Blankenstein, Mark
Looman, Caspar W. N.
Kruijshaar, Michelle E.
Siersema, Peter D.
Kuipers, Ernst J.
Bytzer, Peter
机构
[1] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands
[3] Glostrup Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark
关键词
Barrett's oesophagus; cancer risk; EM algorithms; epidemiology; oesophageal adenocarcinoma;
D O I
10.1080/00365520600884130
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. A recent study of adenocarcinoma of the oesophagus (ACO) incidence rates in Denmark showed a steep fall in the over-80 population, interpreted as the result of a decline in the prevalence of Barrett's oesophagus (BO) in this age group, for which three hypotheses were advanced: the specific mortality from ACO and, superimposed, either excess mortality from causes of death unrelated to ACO or a birth cohort effect. The aim of this study was to create models estimating the BO population fitting each of these three hypotheses, in order to select the most plausible hypothesis and to gain insight into the Danish BO population. Material and methods. Models were designed for these three hypotheses, conforming to the generally accepted 0.4 - 0.5% annual ACO incidence in BO patients. These models employed expectation-maximization ( EM) algorithms, Danish life tables and the observed ACO incidence rates. The models enabled the estimation of a BO population for each hypothesis. Results. After testing against set criteria, the most plausible model was found to be that describing a birth cohort effect which predicted a +/- 5% annual rise in the prevalence of BO and, consequently, in the incidence rate of ACO in Denmark. This prediction was borne out over the subsequent decade. Conclusions. This rising ACO incidence rate is likely to continue into the foreseeable future. The use of EM algorithms enabled a first estimate of the BO population at risk of ACO, although, owing to the limitations imposed by the models, the age- and gender-specific ACO risk for the entire Danish BO population could not as yet be ascertained.
引用
收藏
页码:308 / 317
页数:10
相关论文
共 50 条
  • [21] Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
    Reid, Brian J.
    Li, Xiaohong
    Galipeau, Patricia C.
    Vaughan, Thomas L.
    [J]. NATURE REVIEWS CANCER, 2010, 10 (02) : 87 - 101
  • [22] Social class and progression of Barrett's oesophagus to oesophageal adenocarcinoma
    Bhattacharjee, Santanu
    Caygill, Christine P. J.
    Watson, Anthony
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (01) : 131 - 132
  • [23] THE PROPORTION OF OESOPHAGEAL ADENOCARCINOMA PATIENTS WITH PRIOR BARRETT'S OESOPHAGUS: RESULTS FROM A LARGE POPULATION BASED COHORT
    Bhat, S.
    Coleman, H. G.
    McManus, D.
    Gavin, A. T.
    Murray, L. J.
    Johnston, B. T.
    [J]. GUT, 2011, 60
  • [24] IDEAL AGE TO SCREEN FOR BARRETT'S OESOPHAGUS AND OESOPHAGEAL ADENOCARCINOMA: MODELLING FROM THE CYTOSPONGE-BEST3 TRIAL
    Tan, W. Keith
    Maroni, Roberta
    Offman, Judith
    di Pietro, Massimiliano
    Honing, Judith
    O'Donovan, Maria
    Sasieni, Peter
    Fitzgerald, Rebecca
    [J]. GUT, 2022, 71 : A3 - A4
  • [25] Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma
    Beales, Ian L. P.
    Vardi, Inna
    Dearman, Leanne
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (08) : 917 - 923
  • [26] Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma
    Barclay, JY
    Morris, A
    Nwokolo, CU
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (02) : 221 - 227
  • [27] Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study
    Anderson, Lesley A.
    Watson, R. G. Peter
    Murphy, Seamus J.
    Johnston, Brian T.
    Comber, Harry
    Mc Guigan, Jim
    Reynolds, John V.
    Murray, Liam J.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (10) : 1585 - 1594
  • [28] GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma
    Pavlov, Kirill
    Honing, Judith
    Meijer, Coby
    Boersma-van Ek, Wytske
    Peters, Frans T. M.
    van den Berg, Anke
    Karrenbeld, Arend
    Plukker, John T. M.
    Kruyt, Frank A. E.
    Kleibeuker, Jan H.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 (01) : 73 - 80
  • [29] The role of DNA damage in the development of Barrett's oesophagus and oesophageal adenocarcinoma
    Olliver, JR
    Hardie, LJ
    Clark, GWB
    Dexter, S
    Chalmers, D
    Wild, CP
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S51 - S52
  • [30] Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma:Results from the FINBAR study
    Lesley A Anderson
    RG Peter Watson
    Seamus J Murphy
    Brian T Johnston
    Harry Comber
    Jim Mc Guigan
    John V Reynolds
    Liam J Murray
    [J]. World Journal of Gastroenterology, 2007, (10) : 1585 - 1594